North America Bioanalytical Testing Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]

No. of Pages: 110    |    Report Code: BMIRE00029563    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Bioanalytical Testing Services Market

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Bioanalytical Testing Services Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

5. North America Bioanalytical Testing Services Market - Key Industry Dynamics

5.1 Key Market Drivers:

5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies

5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics

5.2 Key Market Restraints:

5.2.1 Challenges in Development and Validation of Bioanalytical Methods

5.3 Key Market Opportunities

5.3.1 Uninterrupted Growth of Pharmaceuticals Industry

5.4 Future Trends

5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases

5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - North America Market Analysis

6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)

7.3 Pharmacokinetics

7.3.1 Overview

7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Biomarkers

7.4.1 Overview

7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Immunogenicity

7.5.1 Overview

7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Virology Testing

7.6.1 Overview

7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.6.2.1 In-Vitro Virology Testing

7.6.2.1.1 Overview

7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.6.3 In-Vivo Virology Testing

7.6.3.1 Overview

7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Cell-Based Assays

7.7.1 Overview

7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

8.1 Overview

8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)

8.3 Cardiovascular

8.3.1 Overview

8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Neurological Diseases

8.4.1 Overview

8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Autoimmune Disorders

8.5.1 Overview

8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Respiratory Diseases

8.6.1 Overview

8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.7 Metabolic Disorders

8.7.1 Overview

8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.8 Oncology

8.8.1 Overview

8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.9 Sexual Health

8.9.1 Overview

8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.10 Bone Disease

8.10.1 Overview

8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8.11 Others

8.11.1 Overview

8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

9.1 Overview

9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)

9.3 Pharmaceutical and Biopharmaceutical Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Contract Research Organization (CRO)

9.4.1 Overview

9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Contract Development and Manufacturing Organization (CDMO)

9.5.1 Overview

9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Bioanalytical Testing Services Market - Country Analysis

10.1 North America Bioanalytical Testing Services Market, Revenue And Forecast To 2030

10.1.1 Overview

10.1.1.1 North America Bioanalytical Testing Services Market, by Country

10.1.1.2 US

10.1.1.2.1 Overview

10.1.1.2.2 US Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.2.3 US Bioanalytical Testing Services Market, by Services

10.1.1.2.3.1 US Bioanalytical Testing Services Market, by Virology Testing

10.1.1.2.4 US Bioanalytical Testing Services Market, by Disease Indication

10.1.1.2.5 US Bioanalytical Testing Services Market, by End User

10.1.1.3 Canada

10.1.1.3.1 Overview

10.1.1.3.2 Canada Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.3.3 Canada Bioanalytical Testing Services Market, by Services

10.1.1.3.3.1 Canada Bioanalytical Testing Services Market, by Virology Testing

10.1.1.3.4 Canada Bioanalytical Testing Services Market, by Disease Indication

10.1.1.3.5 Canada Bioanalytical Testing Services Market, by End User

10.1.1.4 Mexico

10.1.1.4.1 Overview

10.1.1.4.2 Mexico Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.4.3 Mexico Bioanalytical Testing Services Market, by Services

10.1.1.4.3.1 Mexico Bioanalytical Testing Services Market, by Virology Testing

10.1.1.4.4 Mexico Bioanalytical Testing Services Market, by Disease Indication

10.1.1.4.5 Mexico Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Bioanalytical Testing Services Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 SGS SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Pharmaron Beijing Co Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Element Materials Technology Group Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 CD BioSciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Charles River Laboratories International Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Eurofins Scientific SE

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Labcorp Drug Development Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Syneos Health Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 KCAS Bioanalytical and Biomarker Services LLC

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 ICON Plc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Intertek Group Plc

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

 

 

List of Tables

Table 1. North America Bioanalytical Testing Services Market Segmentation

Table 2. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services

Table 3. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing

Table 4. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication

Table 5. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User

Table 6. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services

Table 7. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing

Table 8. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication

Table 9. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User

Table 10. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services

Table 11. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing

Table 12. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication

Table 13. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User

Table 14. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market

Table 15. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market

Table 16. Glossary of Terms, North America Bioanalytical Testing Services Market

List of Figures

Figure 1. North America Bioanalytical Testing Services Market Segmentation, By Country

Figure 2. North America - PEST Analysis

Figure 3. North America Bioanalytical Testing Services Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

Figure 6. North America Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)

Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. North America Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)

Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. North America Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)

Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

Figure 30. North America Bioanalytical Testing Services Market, by Country - Revenue 2022 ($Mn)

Figure 31. North America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)

Figure 32. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)

Figure 33. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)

Figure 34. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35. Growth Strategies in the Bioanalytical Testing Services Market

The List of Companies - North America Bioanalytical Testing Services Market

1. SGS SA
2. Pharmaron Beijing Co Ltd
3. Element Materials Technology Group Ltd
4. CD BioSciences Inc
5. Charles River Laboratories International Inc
6. Eurofins Scientific SE
7. Labcorp Drug Development Inc
8. Syneos Health Inc
9. KCAS Bioanalytical Biomarker Services LLC
11. ICON Plc,
12. Intertek Group Plc